[68Ga]Ga-DOTA-TOC PET/CT in the localization of head and neck paraganglioma compared with [18F]FDOPA PET/CT and [123I]MIBG SPECT/CT-Reference-Cited by-同舟云学术

[68Ga]Ga-DOTA-TOC PET/CT in the localization of head and neck paraganglioma compared with [18F]FDOPA PET/CT and [123I]MIBG SPECT/CT

Published:2019-04 Issue: Volume:71 Page:47-53
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Kroiss Alexander Stephan,Uprimny Christian,Shulkin Barry Lynn,Gruber Leonhard,Frech Andreas,Url Christoph,Riechelmann Herbert,Sprinzl Georg Mathias,Thomé Claudius,Treglia Giorgio,Kjaer Andreas,Fraedrich Gustav,Virgolini Irene Johanna

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference31 articles.

1. Imaging of pheochromocytoma and paraganglioma;Brink;Fam Cancer,2005

2. Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma;Timmers;J Clin Endocrinol Metab,2009

3. Magnetic resonance imaging or metaiodobenzylguanidine scintigraphy for the demonstration of paragangliomas? Correlations and disparities;van Gils;Eur J Nucl Med,1994

4. Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison;Maurea;Q J Nucl Med,1996

5. 111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas;Koopmans;J Nucl Med,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SDH-related head and neck paragangliomas: Unraveling PET radiomics beyond 18F-FDG;Best Practice & Research Clinical Endocrinology & Metabolism;2024-08

2. Head-to-head comparison between [68Ga]Ga-DOTA-NOC and [18F]DOPA PET/CT in a diverse cohort of patients with pheochromocytomas and paragangliomas;European Journal of Nuclear Medicine and Molecular Imaging;2024-02-01

3. Imaging of Pheochromocytomas and Paragangliomas;Endocrine Reviews;2024-01-11

4. Primäre und sekundäre Lebertumore – aus Sicht der Nuklearmedizin;Angewandte Nuklearmedizin;2023-12

5. Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma;Seminars in Nuclear Medicine;2023-07